For specialists

Macrolides: Significance and Safety for the Treatment of Pneumonia
Mitochondrial dysfunction in neurodegenerative disorders: from pathogenesis to therapy
Published in a journal «International Journal of Neurology» Vol 16 № 4’2020
The effectiveness of a combination of physiotherapeutic methods with local forms of non-steroidal anti-inflammatory drugs in the complex treatment of pain in rheumatology
Published in a journal «Pain Medicine» Vol 3 № 1’2018
The incidence of bacterial conjunctivitis and the antibacterial activity of drugs in their treatment
Published in the journal «Ophthalmology. Eastern Europe» Vol 9 № 4’2019
...And good health in the new year!
Combined urogenital infection and features of its treatment
Published in the journal «Medical Aspects of Men's Health» № 3 (30)’2018
Antibiotic therapy in pregravid preparation of women at risk of intrauterine infection
Published in a journal «Women's Health» № 10 (126)’2017
The combination of Levoximed and Secnidox drugs in the treatment of pelvic inflammatory disease (PID)
Published in a journal «Women's Health» № 7 (113)’2016
Efficiency of methods of postoperative correction of metabolic homeostasis in patients with acute peritonitis
Published in a journal «Pain, Anaesthesia and Intensive Care» № 2 (83)’2018
Elfunate in the treatment of patients with discirculatory encephalopathy
Published in the journal «Neurology and Neurosurgery. Eastern Europe» Vol 7 № 3’2017

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design